2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

Damian Marshall

Session 11 – From Precision Medicine to Precision Health
Date: 24 July (Friday) 10:40 – 12:10 (GMT+8)
Venue: 701EF, 7F, TaiNEX2 / Online event platform


Damian Marshall

Director of New Technologies
Cell and Gene Therapy Catapult




 

Dr Damian Marshall is the Director of New Technologies at the Cell and Gene Therapy Catapult and has almost 20 years of industrial experience in ATMP development working for SME’s and large companies. He leads a team of ~70 scientist who collaborate with a wide range of cell and gene therapy companies to integrate innovative technologies to improve the manufacture of viral vectors and cell-based therapies. The team also focusses on high content analytics for product characterisation and has established a leading position in the integration of Process Analytical Technologies (PAT) for advanced bioprocess control.


Speech title & Synopsis

The Emerging Role of Data Analytics in Cell and Gene Therapy Development

Developing manufacturing strategies which can service the growing global demand for high quality cell and gene therapy products is a significant challenge. This is creating an industry to pull for more advanced process control and smarter manufacturing technologies. In this presentation we will demonstrate how metabolomics and Raman spectroscopy can be applied as part of a Process Analytical Technology (PAT) strategy to deliver increased bioprocess control and real time product monitoring.​